LONDON, UK, August 08, 2009
/24-7PressRelease/ -- The market for aneurysm flow modulating devices is still in the embryonic stage with windows of opportunities opening for early entrants, according to a new Medtech Report:
http://www.medtech-reports.com/aneurysm-flow-modulating-device-market.htm
With ev3 (EVVV) valuing Chestnut Medical Pipeline Embolization Device Technology at $150 million and forecasting a market of $350 million for cerebral flow diversion devices by 2013, the floodgates for innovation in the paradigm-shifting field of aneurysm flow modulation have just been blown away.
Due to the novelty of the paradigm-shifting technology, little notice was taken of the market potential by large multinationals until ev3 adopted, and started publicizing the technology.
The unmet medical need is vast, from difficult to coil wide-necked cerebral aneurysms to hard-to-repair thoraco-abdominal aortic aneurysms, and the technology is proving itself to be safe, logical and accessible to small & medium size entrepreneurial start-ups.
Medtech Ventures' Aneurysm Flow Modulating Device Market - Current Status & Strategic Opportunities is the first report to cover the market of flow-diverting devices for aneurysm reconstruction and repair.
The report offers an exclusive introduction to this emerging market and provides a thorough, analysis of both the technology and markets with analysis of existing markets for cerebral, abdominal aortic, thoracic aortic and peripheral aneurysms, profiles of leading participants and forecasts to the year 2015. Copies of the report are available at:
http://www.medtech-reports.com
About Medtech Wire
Medtech Reports aggregates strategy-level medical technology industry forecasting documents from a select group of consulting firms and market research publishers. For more information please visit website at:
http://www.medtech-reports.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Clyve Parker:Other Press Release Headlines:
